A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
NCT ID: NCT00664248
Last Updated: 2008-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1414 participants
INTERVENTIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
IDP-110
Topical application for 12 weeks
2
Clindamycin
Topical application for 12 weeks
3
Benzoyl peroxide
Topical application for 12 weeks
4
Vehicle
Topical application for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IDP-110
Topical application for 12 weeks
Clindamycin
Topical application for 12 weeks
Benzoyl peroxide
Topical application for 12 weeks
Vehicle
Topical application for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
12 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dow Pharmaceutical Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dow Pharmaceutical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Total Skin and Beauty Dermatology Center
Birmingham, Alabama, United States
University of Alabama, Birmingham
Birmingham, Alabama, United States
Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States
Dermatology Research of Arkansas
Little Rock, Arkansas, United States
Affiliated Research Institute - Dermatology
San Diego, California, United States
Therapeutics Clinical Research
San Diego, California, United States
University of California, San Diego, Pediatric and Adolescent Dermatology
San Diego, California, United States
Solano Clinical Research
Vallejo, California, United States
Dermatology Specialists, Inc.
Vista, California, United States
Clinical Research Specialists
West Santa Monica, California, United States
Cherry Creek Dermatology Research Inc.
Denver, Colorado, United States
Longmont Medical Research Network
Longmont, Colorado, United States
International Dermatology Research, Inc.
Miami, Florida, United States
FXM Research
Miami, Florida, United States
Office of Scott Glazer, MD
Buffalo Grove, Illinois, United States
Henry Ford Medical Center
Detroit, Michigan, United States
The Nevada Center for Dermatology
Reno, Nevada, United States
Academic Dermatology
Albuquerque, New Mexico, United States
Triangle Medical Research Associates
Cary, North Carolina, United States
Unifour Medical Research Associates
Hickory, North Carolina, United States
Wake Research Associates, LLC
Raleigh, North Carolina, United States
New Haven Medical Research
Wilmington, North Carolina, United States
Northwest Cutaneous Research Specialists
Portland, Oregon, United States
Oregon Medical Center, PC
Portland, Oregon, United States
Rivergate Dermatology
Goodlettsville, Tennessee, United States
Dermatology Associates
Knoxville, Tennessee, United States
Dermatology Research Associates
Nashville, Tennessee, United States
Tennessee Clinical Research Center
Nashville, Tennessee, United States
The Center for Skin Research
Houston, Texas, United States
Progressive Clinical Research
San Antonio, Texas, United States
Dermatology Resarch Center
Salt Lake City, Utah, United States
Advanced Clinical Research - Jordan Valley
West Jordan, Utah, United States
Advanced Healthcare
Milwaukee, Wisconsin, United States
Dermatology and Skin Surgery Centre
Belize City, , Belize
Mediprobe Research
New London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DPSI-06-22-2006-012
Identifier Type: -
Identifier Source: org_study_id